Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 38.91%
March 31, 2026 37.44%
December 31, 2025 40.98%
September 30, 2025 38.29%
June 30, 2025 37.42%
March 31, 2025 36.35%
December 31, 2024 36.87%
September 30, 2024 42.78%
June 30, 2024 47.07%
March 31, 2024 44.88%
December 31, 2023 46.97%
September 30, 2023 49.72%
June 30, 2023 30.86%
March 31, 2023 42.47%
December 31, 2022 40.48%
September 30, 2022 39.94%
June 30, 2022 34.65%
March 31, 2022 35.89%
December 31, 2021 42.68%
September 30, 2021 39.82%
June 30, 2021 53.25%
March 31, 2021 65.42%
December 31, 2020 60.75%
September 30, 2020 63.09%
June 30, 2020 59.00%
Date Value
March 31, 2020 51.05%
December 31, 2019 60.08%
September 30, 2019 60.15%
June 30, 2019 64.44%
March 31, 2019 60.02%
December 31, 2018 69.07%
September 30, 2018 62.21%
June 30, 2018 59.36%
March 31, 2018 58.27%
December 31, 2017 54.83%
September 30, 2017 58.24%
June 30, 2017 63.41%
March 31, 2017 62.40%
December 31, 2016 67.48%
September 30, 2016 70.31%
June 30, 2016 67.24%
March 31, 2016 69.83%
December 31, 2015 67.72%
September 30, 2015 69.22%
June 30, 2015 68.11%
March 31, 2015 62.75%
December 31, 2014 62.68%
September 30, 2014 67.18%
June 30, 2014 60.66%
March 31, 2014 59.17%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%
Baxter International, Inc. 33.55%

Gross Profit Margin (Quarterly) Related Metrics